FDA Inspection 1230610 — Baxter Healthcare Corporation
The FDA completed an inspection of Baxter Healthcare Corporation on Feb 6, 2024 in Deerfield, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 6, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Deerfield, IL (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)